Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘VBI Vaccines Inc. (VBIV)’

Happy Stock Trading Bull Market NYSE Insider Trading hedge funds

Hedge Fund and Insider Trading News: Sahm Adrangi, Bernard Selz, Stryker Corporation (SYK), VBI Vaccines Inc (VBIV), and More

Woodford’s Hedge Fund foe Rules out a Return to Shorting his Holdings (FNLondon.com) Kerrisdale Capital, the US hedge fund that made a public enemy......(read more)
trade, forex, investment, gain, stock, phone, network, view, report, money, smart, background, broker, market, laptop, table, economy, display, loss, business, urban,

Hedge Fund and Insider Trading News: Eddie Lampert, Steven Cohen, Synergy CHC Corp (SNYR), Marijuana Company Of America Inc (MCOA), Cracker Barrel Old Country Store, Inc. (CBRL), and More

Kmart Was Once Rescued from Bankruptcy by Eddie Lampert. It’s Unclear Whether it will Happen Again (CNBC) Much has changed in retail over the past 16......(read more)
10 Countries with the Highest Autism Rates in the World in 2017

13D Filing: Perceptive Advisors and VBI Vaccines, Inc. (VBIV)

VBI Vaccines, Inc. (NASDAQ:VBIV): Joseph Edelman’s Perceptive Advisors filed an amended 13D. You can check out Perceptive Advisors’ latest......(read more)
15 Countries With the Most Plastic Surgery Per Capita in the World

VBI Vaccines, Inc. (VBIV) Gets European Support For Pivotal Phase III Sci-B-Vac Trial

Risks in biotech investment tend to increase as a young company gets closer and closer to its first FDA approval. Trials become more expensive, expectations......(read more)
test, cancer, researcher, research, dna, bio, clean, modern, chemistry, human, white, medical, sample, pipette, life, culture, laboratory, biotechnology, genetic, disease,

$23.6M Investment From 2015’s Top Performing Hedge Fund Makes VBI Vaccines, Inc. (VBIV) Even More Undervalued

One would think that a hepatitis B vaccine with 100% efficacy, negligible safety issues, and mountains of clinical data already supporting it would be......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

New Phase IV Data On VBI Vaccines, Inc. (VBIV) HBV Vaccine Show It Can Carve Out A Market From GlaxoSmithKline PLC (ADR) (GSK)

No stock is ever a sure thing, but that doesn’t mean you can’t get asymptotically close to one. Following the announcement by VBI Vaccines, Inc. (......(read more)